GRIFOLS news, videos and press releases - Page 4
For more news please use our advanced search feature.
GRIFOLS - More news...
GRIFOLS - More news...
- Grifols US donor centers exceed 250,000 pounds of food collected
- Grifols donations of blood clotting factor helping people with hemophilia globally
- Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019
- Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR
- Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year
- Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
- Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
- Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions
- Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol
- FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
- Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support
- Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio
- Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
- Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System
- Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
- Grifols Launches a New Testing Service for Patients Treated with Daratumumab
- Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
- Grifols donates over 25 million international units of blood clotting factor in 2017
- Report: Exploring Fundamental Drivers Behind Itau Unibanco Holding S.A, Weibo, Redhill Biopharma, Shenandoah Telecommunications, Grifols, S.A, and Orthofix International N.V — New Horizons, Emerging Trends, and Upcoming Developments
- Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018
- Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S.
- Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD"
- Grifols HyperRAB® (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
- Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program
- Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017
-
Grifols
- Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million
- Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million
- Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion
- Grifols Opens Diagnostic Training Center in Dubai